NHS Dudley Health Economy Medicines Formulary
Home > 11 Eye > 11.8 Miscellaneous ophthalmic preparations > 11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment > Colorectal cancer (metastatic) - aflibercept NICE TAG TA307

Colorectal cancer (metastatic) - aflibercept NICE TAG TA307

1.1 Aflibercept in combination with irinotecan and fluorouracil-based therapy is not recommended within its marketing authorisation for treating metastatic colorectal cancer that is resistant to or has progressed after an oxaliplatin-containing regimen.

1.2 People currently receiving aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that is resistant to or has progressed after an oxaliplatin-containing regimen should be able to continue treatment until they and their clinician consider it appropriate to stop.

https://www.nice.org.uk/guidance/TA307 

Site by Devopa
© Copyright 2021 NHS. All rights reserved.